Wan-Jen Hong - 18 Jul 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role: Chief Medical Officer
Signature: /s/ Hugh Rienhoff, as Attorney-in-fact for Wan-Jen Hong
Issuer symbol: N/A
Transactions as of: 18 Jul 2022
Net transactions value: +$7,060
Form type: 4
Filing time: 20 Jul 2022, 17:39:46 UTC
Previous filing: 19 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMGO	Common Stock	Options Exercise	$7,060	+1,000		$7.06^*	1,000	18 Jul 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMGO	Stock Option (Right to Buy)	Disposed to Issuer	$0	-1,000	-0.39%	$0.000000	258,523	18 Jul 2022	Common Stock	1,000	$7.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests with respect to 25% of the shares subject thereto on May 24, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Content

The option vests with respect to 25% of the shares subject thereto on May 24, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.